334 related articles for article (PubMed ID: 1371722)
21. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples.
Birken S; Chen Y; Gawinowicz MA; Lustbader JW; Pollak S; Agosto G; Buck R; O'Connor J
Endocrinology; 1993 Sep; 133(3):1390-7. PubMed ID: 7689955
[TBL] [Abstract][Full Text] [Related]
22. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
Shapiro AI; Wu TF; Ballon SC; Lamb EJ
Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254
[TBL] [Abstract][Full Text] [Related]
23. Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine.
Cole LA; Seifer DB; Kardana A; Braunstein GD
Am J Obstet Gynecol; 1993 May; 168(5):1580-6. PubMed ID: 8498446
[TBL] [Abstract][Full Text] [Related]
24. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
26. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
[TBL] [Abstract][Full Text] [Related]
27. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
[TBL] [Abstract][Full Text] [Related]
28. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
Kitajima T; Mochizuki M; Nishimura R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
[TBL] [Abstract][Full Text] [Related]
29. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
30. A specific and sensitive sandwich enzyme immunoassay for human chorionic gonadotropin using antibodies against the carboxyl-terminal portion of the beta-subunit.
Kondo K; Imagawa M; Iwasa S; Kitada C; Konishi E; Suzuki N; Yamoto M; Nakano R; Yoshitake S; Ishikawa E
Clin Chim Acta; 1984 Apr; 138(2):229-35. PubMed ID: 6327121
[No Abstract] [Full Text] [Related]
31. Monoclonal antibodies to human chorionic gonadotropin (HCG) and their use in two-site binding enzyme immunoassays.
Böttger V; Micheel B; Scharte G; Kaiser G; Wolf G; Schmechta H
Hybridoma; 1993 Feb; 12(1):81-91. PubMed ID: 7681037
[TBL] [Abstract][Full Text] [Related]
32. Discordant human chorionic gonadotropin results: causes and solutions.
Hussa RO; Rinke ML; Schweitzer PG
Obstet Gynecol; 1985 Feb; 65(2):211-9. PubMed ID: 3969234
[TBL] [Abstract][Full Text] [Related]
33. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
[TBL] [Abstract][Full Text] [Related]
34. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotropin beta-subunit nicking enzymes in pregnancy and cancer patient serum.
Kardana A; Cole LA
J Clin Endocrinol Metab; 1994 Sep; 79(3):761-7. PubMed ID: 7521352
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
37. [Detection of hCG serum levels in choriocarcinoma using monoclonal antibodies].
Vlachová J; Zavadil M; Jakoubková J; Skrivan J; Minajev G
Cesk Gynekol; 1989 Apr; 54(3):179-84. PubMed ID: 2766368
[TBL] [Abstract][Full Text] [Related]
38. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia.
Wu T; Ballon SC; Teng NN
Am J Obstet Gynecol; 1983 Dec; 147(7):821-5. PubMed ID: 6196974
[TBL] [Abstract][Full Text] [Related]
40. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
